Cancer readouts Madrid 2026: Hazard Ratio (HR) ≤0.70 to triage

Use HR ≤0.70 to triage cancer biomarker readouts in Madrid 2026. Confirm in a prespecified independent cohort and lock assay precision before unblinding. Independent technical note mirroring the canonical version: https://quantbio.me/blog/cancer-readouts-madrid-2026-hazard-ratio-hr-070-to-triage.php

Authors

Dr. Leah Fontaine

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2026-11-09
DOI: https://doi.org/10.5281/zenodo.24080096
Primary Topic: Cancer Genomics and Diagnostics
Type: preprint

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

NOV

preprint

Cancer readouts Madrid 2026: Hazard Ratio (HR) ≤0.70 to triage

Dr. Leah Fontaine

Nov 9, 2026

Zenodo (CERN European Organization for Nuclear Research)

Cancer Genomics and Diagnostics

preprint

Cancer readouts Madrid 2026: Hazard Ratio (HR) ≤0.70 to triage

Dr. Leah Fontaine

November 9, 2026preprint en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Cancer Genomics and Diagnostics

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon

Cancer readouts Madrid 2026: Hazard Ratio (HR) ≤0.70 to triage — Dr. Leah Fontaine · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS